DIP
WST icon

DT Investment Partners’s West Pharmaceutical WST Stock Holding History

DT Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-41
Closed -$9.18K – 555
2025
Q1 		$9.18K Hold
41
– – ﹤0.01% 420
2024
Q4 		$13.4K Hold
41
– – ﹤0.01% 373
2024
Q3 		$12.3K Hold
41
– – ﹤0.01% 419
2024
Q2 		$13.5K Hold
41
– – ﹤0.01% 353
2024
Q1 		$16.2K Hold
41
– – ﹤0.01% 304
2023
Q4 		$15.4K Hold
41
– – ﹤0.01% 296
2023
Q3 		$15.4K Hold
41
– – ﹤0.01% 278
2023
Q2 		$15.2K Hold
41
– – ﹤0.01% 287
2023
Q1 		$15K Hold
41
– – ﹤0.01% 283
2022
Q4 		$9.65K Hold
41
– – ﹤0.01% 332
2022
Q3 		$10K Buy
+41
New +$12.5K ﹤0.01% 306

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

DT Investment Partners's WST Position: Q2 2025 in Review

DT Investment Partners sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 41 shares — an estimated $9.18K sold.

DT Investment Partners first reported a position in WST in Q3 2022 and held it in 11 quarters. The position peaked at $16.2K in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • DT Investment Partners reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • DT Investment Partners sold 41 West Pharmaceutical shares in Q2 2025, an estimated $9.18K.
  • DT Investment Partners first reported a position in West Pharmaceutical in Q3 2022 and held it in 11 quarters.
  • DT Investment Partners's West Pharmaceutical position peaked at $16.2K in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on DT Investment Partners's 13F filing for Q2 2025, filed 22 Jul 2025.